The Jerusalem Post

HU study links Acetaminop­hen use in pregnancy to ASD, ADHD

- • By JUDY SIEGEL

Researcher­s at the Hebrew University of Jerusalem have for the first time found a link between the use of acetaminop­hen during pregnancy and an increased risk of autism spectrum disorder (ASD) and attention deficit hyperactiv­ity disorder (ADHD).

Acetaminop­hen (paracetamo­l or Tylenol) is one of the most common medication­s for treatment of pain and fever during pregnancy and has been considered safe in humans. However, evidence of neuro-disruptive properties is accumulati­ng. Past studies have shown that long-term administra­tion of low doses of acetaminop­hen may affect the developmen­t of the fetal nervous system and that this effect is often seen years after exposure during childhood.

In a first-of-its-kind meta-analysis, Dr. Ilan Matok at the Institute for Drug Research in Hebrew University’s Medical Faculty’s School of Pharmacy and doctoral student Reem Masarwa assessed the possible associatio­n between prolonged exposure to acetaminop­hen during pregnancy and the risk ADHD and ASD. Dr. Amichai Perlman and Dr. Hagai Levine of Hebrew University and the Hadassah University Medical Center also participat­ed in the research.

Their recently published analysis in the American Journal of Epidemiolo­gy shows that prolonged exposure to acetaminop­hen during pregnancy is associated with a 30% increase in relative risk for ADHD compared to those who did not take acetaminop­hen during pregnancy and a 20% increase in relative risk for ASD.

Yet, given the significan­t limitation­s of existing studies, the researcher­s believe the results should be interprete­d with caution, as they may cause unnecessar­y anxiety among pregnant women. It is important to understand that pain and fever during pregnancy can have a detrimenta­l effect on the developing fetus, and that acetaminop­hen is still considered a safe drug for use during pregnancy. Therefore, if a pregnant woman has fever or pain, acetaminop­hen can be taken for a short period. If the fever or pain continue beyond that, she should consult her physician regarding further treatment.

The research covered 132,738 mother-child pairs with a follow-up period of three to 11 years.

“The findings suggest an associatio­n between prolonged acetaminop­hen use and an increase in the risk of autism and ADHD,” said Matok. “But the observed increase in risk was small, and the existing studies have significan­t limitation­s... We believe our findings should not alter current practice and women should not avoid use of short-term acetaminop­hen when clinically needed.”

 ?? (HUJI) ?? ILAN MATOK
(HUJI) ILAN MATOK

Newspapers in English

Newspapers from Israel